⌘K

Login Start Free

Home/Filings/4/0001493152-20-007256

4//SEC Filing

Brandt Ralf 4

Accession 0001493152-20-007256

CIK 0001349929other

View on SEC.gov Company Profile

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 4:01 PM ET

Size

5.4 KB

Accession

0001493152-20-007256

Insider Transaction Report

Form 4

Period: 2020-01-02

CANCER GENETICS, INCCGIX

President, Discovery Services

Transactions

Award
Stock Option (right to buy)
2020-01-02+10,000→ 10,000 total
Exercise: $5.53From: 2020-02-02Exp: 2030-01-02→ Common Stock, par value $0.0001 per share (10,000 underlying)

Footnotes (1)

[F1]The options vest monthly in twelve equal installments beginning on February 2, 2020.

Documents

1 file

4
ownership.xmlPrimary

Issuer

CANCER GENETICS, INC

CIK 0001349929

Entity typeother

Related Parties

1

filerCIK 0001715437

Filing Metadata

Form type: 4
Filed: Apr 27, 8:00 PM ET
Accepted: Apr 28, 4:01 PM ET
Size: 5.4 KB

View on SEC.gov